List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 5428 studies with search of:   Canada
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
21 Recruiting Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases
Conditions: Metastatic Cancer;   Prostate Cancer
Interventions: Drug: placebo;   Drug: zoledronic acid
22 Completed Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo.
Condition: Cardiovascular Diseases
Interventions: Drug: Telmisartan;   Drug: Combination of Telmisartan and Ramipril;   Drug: Ramipril
23 Completed Safety of Daily Dose Esomeprazole for GERD for Pediatric and Adolescent Patients
Condition: Gastroesophageal Reflux Disease (GERD)
Intervention: Drug: Esomeprazole
24 Completed Chest Pain Pilot Study
Conditions: Chest Pain;   Gastroesophageal Reflux
Intervention: Drug: Esomeprazole
25 Completed Iressa vs Best Supportive Care - 2nd/3rd Line Survival Study
Condition: NSCLC
Intervention: Drug: Gefitinib
26 Active, not recruiting The DURABLE Trial: Evaluating the Durability of Starter Insulin Regimens in Patients With Type 2 Diabetes (IOOV)
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Glargine;   Drug: Humalog Low Mix
27 Active, not recruiting Combination Therapy for Age-Related Macular Degeneration.
Condition: Age Related Macular Degeneration
Interventions: Drug: Avastin (Bevacizumab);   Drug: Bevacizumab;   Drug: Bevacizumab;   Drug: Bevacizumab
28 Terminated A Long-Term Study To Examine The Effects Of CP-945,598 On Weight Loss And Safety
Condition: Obesity
Interventions: Drug: CP-945,598 Treatment A;   Drug: CP-945,598 Treatment B;   Drug: Placebo
29 Recruiting Assessment and Tracking of Long-Term Alefacept Safety
Condition: Psoriasis
Intervention: Drug: Alefacept exposure
30 Recruiting A Canadian Study Evaluating the Clinical Benefit of SEROQUEL XR in Subjects With Schizophrenia
Condition: Schizophrenia
Intervention: Drug: Quetiapine Fumarate Extended- Release
31 Recruiting Safety and Efficacy of LibiGel® for Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women
Condition: Hypoactive Sexual Desire Disorder
Interventions: Drug: testosterone;   Drug: placebo
32 Recruiting Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism
Condition: Venous Thrombosis
Interventions: Drug: Enoxaparin;   Drug: warfarin;   Drug: Placebo for apixaban;   Drug: Placebo for enoxaparin;   Drug: Placebo for warfarin;   Drug: apixaban
33 Recruiting LOGiC - Lapatinib Optimization Study in ErbB2 (HER2) Positive Gastric Cancer: A Phase III Global, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus Lapatinib
Conditions: ErbB2 (HER2) Amplified Gastric;   Esophageal;   or Gastro-Esophageal Junction Adenocarcinoma That is Unresectable Due to Locally Advanced Metastatic, or Locally Recurrent Disease.
Intervention: Drug: Lapatinib
34 Completed Study of Two Doses of GSK Biologicals' Live Attenuated HRV Vaccine (Two Different Formulations) in Healthy Infants.
Condition: Rotavirus Gastroenteritis
Interventions: Biological: Human Rotavirus Vaccine - two different formulations;   Biological: Prevnar;   Biological: IPOL;   Biological: Infanrix;   Biological: OmniHIB;   Biological: Pentacel;   Biological: Placebo
35 Active, not recruiting Radiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer
Condition: Prostate Cancer
Intervention: Procedure: radiation therapy
36 Completed Combination Chemotherapy, Radiation Therapy, and RSR13 in Treating Patients With Stage III Non-Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Drug: carboplatin;   Drug: efaproxiral;   Drug: paclitaxel;   Procedure: chemotherapy;   Procedure: radiation therapy
37 Completed Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma
Conditions: Brain and Central Nervous System Tumors;   Lymphoma;   Neuroblastoma;   Retinoblastoma;   Sarcoma;   Unspecified Childhood Solid Tumor, Protocol Specific
Intervention: Drug: becatecarin
38 Completed Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Condition: Leukemia
Interventions: Drug: asparaginase;   Drug: cyclophosphamide;   Drug: cytarabine;   Drug: daunorubicin hydrochloride;   Drug: dexamethasone;   Drug: doxorubicin hydrochloride;   Drug: leucovorin calcium;   Drug: mercaptopurine;   Drug: methotrexate;   Drug: nelarabine;   Drug: pegaspargase;   Drug: prednisone;   Drug: thioguanine;   Drug: vincristine sulfate;   Procedure: radiation therapy
39 Active, not recruiting Comparison of Combination Chemotherapy Regimens in Treating Older Women Who Have Undergone Surgery for Breast Cancer
Condition: Breast Cancer
Interventions: Drug: CMF regimen;   Drug: capecitabine;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: fluorouracil;   Drug: methotrexate;   Procedure: adjuvant therapy
40 Active, not recruiting Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: lomustine;   Drug: temozolomide;   Procedure: adjuvant therapy;   Procedure: radiation therapy

Previous Page (1-20) Studies Shown (21-40) Next (41-60)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services